| Cash flows from operating activities: | |
| Net income (loss) | -3.35M |
| Adjustments to reconcile net income (loss) to cash (used in) provided by operating activities: | |
| Depreciation and amortization | 1.27M |
| Provision for doubtful accounts | |
| Stock-based compensation expense | 543K |
| Change in fair value of warrant liability | -5K |
| Changes in operating assets and liabilities: | |
| Accounts receivable | -98K |
| Note receivable | 50K |
| Prepaid expenses and other | -359K |
| Accounts payable and accrued liabilities | 2.25M |
| Deferred revenue | 40K |
| Net cash (used in) provided by operating activities | 1.06M |
| Cash flows from investing activities: | |
| Capital expenditures | -635K |
| Issuance of notes receivable | |
| Proceeds from notes receivable | |
| Acquisitions, net of cash acquired | |
| Purchases of intangible assets | |
| Net cash used in investing activities | -635K |
| Cash flows from financing activities: | |
| Proceeds from the exercise of warrants | |
| Proceeds from the exercise of options | 1K |
| Proceeds from the public offering of common stock | |
| Payment of revolving credit facility | -958K |
| Proceeds from revolving credit facility | |
| Payment of financing related costs | -94K |
| Net cash provided by financing activities | -1.05M |
| Net increase in cash and cash equivalents | |
| Cash and cash equivalents, beginning of the period | 3.7M |
| Cash and cash equivalents, end of the period | 3.07M |
| Supplemental cash flow information: | |
| Interest paid | 118K |
| Income taxes paid | 0 |